BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26149494)

  • 1. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.
    Kober C; Rohn S; Weibel S; Geissinger U; Chen NG; Szalay AA
    J Transl Med; 2015 Jul; 13():216. PubMed ID: 26149494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro.
    Goncharova EP; Ruzhenkova JS; Petrov IS; Shchelkunov SN; Zenkova MA
    J Transl Med; 2016 Aug; 14(1):241. PubMed ID: 27538520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.
    Kober C; Weibel S; Rohn S; Kirscher L; Szalay AA
    Mol Ther Oncolytics; 2015; 2():15009. PubMed ID: 27119106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.
    Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B
    Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection.
    Grekova SP; Raykov Z; Zawatzky R; Rommelaere J; Koch U
    Cancer Gene Ther; 2012 Jul; 19(7):468-75. PubMed ID: 22539062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenografts.
    Advani SJ; Buckel L; Chen NG; Scanderbeg DJ; Geissinger U; Zhang Q; Yu YA; Aguilar RJ; Mundt AJ; Szalay AA
    Clin Cancer Res; 2012 May; 18(9):2579-90. PubMed ID: 22379115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis.
    Ku MC; Wolf SA; Respondek D; Matyash V; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Synowitz M; Glass R; Kettenmann H
    Acta Neuropathol; 2013 Apr; 125(4):609-20. PubMed ID: 23344256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
    Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
    Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase.
    Hu W; Hofstetter W; Guo W; Li H; Pataer A; Peng HH; Guo ZS; Bartlett DL; Lin A; Swisher SG; Fang B
    Cancer Gene Ther; 2008 Sep; 15(9):616-24. PubMed ID: 18535619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
    Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
    Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.
    Mantwill K; Naumann U; Seznec J; Girbinger V; Lage H; Surowiak P; Beier D; Mittelbronn M; Schlegel J; Holm PS
    J Transl Med; 2013 Sep; 11():216. PubMed ID: 24044901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection.
    Weibel S; Raab V; Yu YA; Worschech A; Wang E; Marincola FM; Szalay AA
    BMC Cancer; 2011 Feb; 11():68. PubMed ID: 21320309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination.
    Byrd D; Shepherd N; Lan J; Hu N; Amet T; Yang K; Desai M; Yu Q
    J Virol; 2014 Jun; 88(12):6819-31. PubMed ID: 24696488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction.
    Resende FF; Bai X; Del Bel EA; Kirchhoff F; Scheller A; Titze-de-Almeida R
    BMC Cancer; 2016 Feb; 16():72. PubMed ID: 26856327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of Aquaporin-1 mediates a microglial phenotype switch affecting glioma growth.
    Hu F; Huang Y; Semtner M; Zhao K; Tan Z; Dzaye O; Kettenmann H; Shu K; Lei T
    Exp Cell Res; 2020 Nov; 396(2):112323. PubMed ID: 33058832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.
    Kilinc MO; Ehrig K; Pessian M; Minev BR; Szalay AA
    J Transl Med; 2016 Dec; 14(1):340. PubMed ID: 27993141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen profiling analysis of vaccinia virus injected canine tumors: oncolytic virus efficiency predicted by boolean models.
    Cecil A; Gentschev I; Adelfinger M; Nolte I; Dandekar T; Szalay AA
    Bioengineered; 2014; 5(5):319-25. PubMed ID: 25482233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3.
    Delwar ZM; Kuo Y; Wen YH; Rennie PS; Jia W
    Cancer Res; 2018 Feb; 78(3):718-730. PubMed ID: 29118089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.